• Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial 

  McCullough, Austin; Chen, Charles D.; Gordon, Brian A.; Joseph-Mathurin, Nelly; Jack Jr, Clifford R; Koeppe, Robert; Hornbeck, Russ; Koudelis, Deborah; McKay, Nicole S.; Hobbs, Diana A.; Flores, Shaney; Keefe, Sarah J.; Aggarwal, Neelum T.; Allegri, Ricardo Francisco; Berman, Sarah B.; Bird, Thomas; Black, Sandra E.; Brooks, William S.; Chhatwal, Jasmeer P.; Day, Gregory S.; DIAN‐TU Study Team (Wiley, 2025-07)

  Introduction: Monoclonal anti-amyloid therapies are now accessible, but how these treatments influence changes within the brain is still not clear. We investigated overall and regional change in amyloid removal, glucose ...
• Advances in migraine prevention 

  Martinelli, Daniele; De Icco, Roberto; Al-Khazali, Haidar M.; Ashina, Sait; Diener, Hans-Christoph; Dodd-Glover, Freda; Goicochea, María Teresa; Jenkins, Bronwyn; MaassenVanDenBrink, Antoinette; Lee, Mi Ji; Özge, Aynur; Prieto Peres, Mario Fernando; Pozo Rosich, Patricia; Puledda, Francesca; Sacco, Simona; Schwedt, Todd J.; Terwindt, Gisela M.; Tassorelli, Cristina (Lancet Pub. Group, 2026-03)

  Migraine imposes a heavy burden on patients and societies. Preventive treatments aimed at reducing the occurrence of migraine attacks and their intensity have been largely underused, leaving a multitude of people with ...
• Systematic review of movement disorders mislabeled as functional : when incongruence misleads 

  Marín-Medina, Daniel S.; Miño Zambrano, Joselyn; Espay, Alberto J.; Merello, Marcelo (Springer-Verlag, 2026-04-08)

  Background: Misdiagnosis of functional movement disorders (FMD) remains a concern for clinicians. We sought to review the phenomenology and clinical features associated with FMD misdiagnosis. Methods: We conducted a ...
• Novel GNAO1 variant in α-helical domain reveals alternative mechanism of disease 

  Ludlam, William Grant; Domínguez-Carral, Jana; Schteinschnaider, Ángeles; Martemyanov, Kirill A.; Ortigoza-Escobar, Juan Darío (Elsevier B.V. on behalf of KeAi Communications Co. Ltd., 2026-03)

  Resumen no disponible.
• Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease 

  Llibre Guerra, Jorge J.; Lu, Ruijin; Clarens, María Florencia; Liu, Ian; Renton, Alan E.; Ryan, Natalie S.; Goate, Alison M.; Aguillón, David; Allegri, Ricardo Francisco; Benzinger, Tammie L.S.; Berman, Sarah B.; Chhatwal, Jasmeer P.; Chrem Méndez, Patricio Alexis; Vigo, Gabriela; Cruchaga, Carlos; Day, Gregory S.; Farlow, Martin R.; Fox, Nick C.; Gordon, Brian A.; Hassenstab, Jason (Lippincott Williams & Wilkins, 2026-04-28)

  Background and objectives: Cognitive reserve has been shown to modulate the onset and progression of Alzheimer disease (AD) symptoms. Although its role in sporadic AD is well-studied, how cognitive reserve influences the ...

Más